ArticleMaterials today. Bio2026

A multitargeting nanoparticle-based vaccine for enhanced anticancer immunotherapy in HER2-Positive breast cancer.

Sen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.